NZ's AFT Pharma eyes highest weekly gain in over 2 months after results
BUZZ-NZ's AFT Pharma eyes highest weekly gain in over 2 months after results ** Shares of AFT Pharmaceuticals AFT.NZ up over 6% so far this week, on track for their best week since late July
** Stock rose 2% to A$4.64 on Friday, poised for fourth straight session of gains
** On Tuesday, the pharmaceutical distributor reported H1FY27 results, where all divisions saw double-digit revenue growth
** AFT also affirmed its FY27 operating profit guidance between NZ$28 million and NZ$32 million ($15.69 million and $17.93 million)** Stock up 32.3% YTD, including session's moves
($1 = 1.7848 New Zealand dollars)
(Reporting by Rudrannsh Mehra in Bengaluru)
Recent news on AFT Pharmaceuticals
See all newsNZ's AFT Pharma eyes highest weekly gain in over 2 months after results
Brief: AFT Pharmaceuticals Reports Double Digit Revenue Growth In 1H FY27
NZ's AFT Pharmaceuticals gains most in over 2 weeks on strong half-year results
Brief: AFT Pharmaceuticals Enters Exclusive Development, License And Supply Agreement With Mikasaseiyaku
NZ's AFT Pharma rises to near 1-month high on Japan licensing deal for Maxigesic IV